The safety of etomidate for emergency rapid sequence intubation of pediatric patients

Peter E. Sokolove, Daniel D. Price, Pamela Okada

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Objective: To determine whether pediatric patients given etomidate for rapid sequence intubation (RSI) in the ED develop clinically important hypotension or adrenal insufficiency. Methods: Retrospective review of 100 consecutive patients younger than age 10 years given etomidate for RSI in the ED at two academic medical centers. Data were abstracted from ED and in- patient medical records. Clinically important hypotension was defined as a decrease in systolic blood pressure (BP) measurement to below one standard deviation (SD) of mean normal for age. Clinically important adrenal insufficiency was defined as the need for exogenous corticosteroid replacement for suspected adrenal insufficiency at any time during hospitalization. Results: BP measurements before and within 20 minutes after etomidate administration for RSI were recorded on 84 intubations (84%). The mean change in BP between pre-intubation and post-intubation measurements was a decrease of 1 mmHg (95% CI: -6 mmHg to +7 mmHg, P = 0.83). When expressed as a percentage of normal BP for age, the mean change in BP was a decrease of 1% (95% CI: -7% to +6%, P = 0.82). Four patients (4.8%; 95% CI: 1.3-11.7%) had a systolic BP decrease to below one SD of mean normal for age. Fourteen patients received corticosteroids during hospitalization, but none (0/99, 95% CI: 0-3.7%) for suspected adrenal insufficiency. Conclusions: We found no evidence of clinically important adrenocorticoid suppression and a low incidence of clinically important hypotension when using etomidate for emergent pediatric RSI. Because other induction agents may also result in hypotension, prospective comparison studies are needed to further evaluate the safety of etomidate in this patient population.

Original languageEnglish (US)
Pages (from-to)18-21
Number of pages4
JournalPediatric Emergency Care
Volume16
Issue number1
DOIs
StatePublished - Feb 2000

Fingerprint

Etomidate
Intubation
Emergencies
Pediatrics
Blood Pressure
Safety
Adrenal Insufficiency
Hypotension
Adrenal Cortex Hormones
Hospitalization
Medical Records
Prospective Studies
Incidence

Keywords

  • Adrenal insufficiency
  • Blood pressure
  • Emergency department
  • Etomidate
  • Intubation
  • Pediatric

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Nursing(all)
  • Emergency Medicine

Cite this

The safety of etomidate for emergency rapid sequence intubation of pediatric patients. / Sokolove, Peter E.; Price, Daniel D.; Okada, Pamela.

In: Pediatric Emergency Care, Vol. 16, No. 1, 02.2000, p. 18-21.

Research output: Contribution to journalArticle

Sokolove, Peter E. ; Price, Daniel D. ; Okada, Pamela. / The safety of etomidate for emergency rapid sequence intubation of pediatric patients. In: Pediatric Emergency Care. 2000 ; Vol. 16, No. 1. pp. 18-21.
@article{f00e090345be4f129de09a91361aa2a3,
title = "The safety of etomidate for emergency rapid sequence intubation of pediatric patients",
abstract = "Objective: To determine whether pediatric patients given etomidate for rapid sequence intubation (RSI) in the ED develop clinically important hypotension or adrenal insufficiency. Methods: Retrospective review of 100 consecutive patients younger than age 10 years given etomidate for RSI in the ED at two academic medical centers. Data were abstracted from ED and in- patient medical records. Clinically important hypotension was defined as a decrease in systolic blood pressure (BP) measurement to below one standard deviation (SD) of mean normal for age. Clinically important adrenal insufficiency was defined as the need for exogenous corticosteroid replacement for suspected adrenal insufficiency at any time during hospitalization. Results: BP measurements before and within 20 minutes after etomidate administration for RSI were recorded on 84 intubations (84{\%}). The mean change in BP between pre-intubation and post-intubation measurements was a decrease of 1 mmHg (95{\%} CI: -6 mmHg to +7 mmHg, P = 0.83). When expressed as a percentage of normal BP for age, the mean change in BP was a decrease of 1{\%} (95{\%} CI: -7{\%} to +6{\%}, P = 0.82). Four patients (4.8{\%}; 95{\%} CI: 1.3-11.7{\%}) had a systolic BP decrease to below one SD of mean normal for age. Fourteen patients received corticosteroids during hospitalization, but none (0/99, 95{\%} CI: 0-3.7{\%}) for suspected adrenal insufficiency. Conclusions: We found no evidence of clinically important adrenocorticoid suppression and a low incidence of clinically important hypotension when using etomidate for emergent pediatric RSI. Because other induction agents may also result in hypotension, prospective comparison studies are needed to further evaluate the safety of etomidate in this patient population.",
keywords = "Adrenal insufficiency, Blood pressure, Emergency department, Etomidate, Intubation, Pediatric",
author = "Sokolove, {Peter E.} and Price, {Daniel D.} and Pamela Okada",
year = "2000",
month = "2",
doi = "10.1097/00006565-200002000-00005",
language = "English (US)",
volume = "16",
pages = "18--21",
journal = "Pediatric Emergency Care",
issn = "0749-5161",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The safety of etomidate for emergency rapid sequence intubation of pediatric patients

AU - Sokolove, Peter E.

AU - Price, Daniel D.

AU - Okada, Pamela

PY - 2000/2

Y1 - 2000/2

N2 - Objective: To determine whether pediatric patients given etomidate for rapid sequence intubation (RSI) in the ED develop clinically important hypotension or adrenal insufficiency. Methods: Retrospective review of 100 consecutive patients younger than age 10 years given etomidate for RSI in the ED at two academic medical centers. Data were abstracted from ED and in- patient medical records. Clinically important hypotension was defined as a decrease in systolic blood pressure (BP) measurement to below one standard deviation (SD) of mean normal for age. Clinically important adrenal insufficiency was defined as the need for exogenous corticosteroid replacement for suspected adrenal insufficiency at any time during hospitalization. Results: BP measurements before and within 20 minutes after etomidate administration for RSI were recorded on 84 intubations (84%). The mean change in BP between pre-intubation and post-intubation measurements was a decrease of 1 mmHg (95% CI: -6 mmHg to +7 mmHg, P = 0.83). When expressed as a percentage of normal BP for age, the mean change in BP was a decrease of 1% (95% CI: -7% to +6%, P = 0.82). Four patients (4.8%; 95% CI: 1.3-11.7%) had a systolic BP decrease to below one SD of mean normal for age. Fourteen patients received corticosteroids during hospitalization, but none (0/99, 95% CI: 0-3.7%) for suspected adrenal insufficiency. Conclusions: We found no evidence of clinically important adrenocorticoid suppression and a low incidence of clinically important hypotension when using etomidate for emergent pediatric RSI. Because other induction agents may also result in hypotension, prospective comparison studies are needed to further evaluate the safety of etomidate in this patient population.

AB - Objective: To determine whether pediatric patients given etomidate for rapid sequence intubation (RSI) in the ED develop clinically important hypotension or adrenal insufficiency. Methods: Retrospective review of 100 consecutive patients younger than age 10 years given etomidate for RSI in the ED at two academic medical centers. Data were abstracted from ED and in- patient medical records. Clinically important hypotension was defined as a decrease in systolic blood pressure (BP) measurement to below one standard deviation (SD) of mean normal for age. Clinically important adrenal insufficiency was defined as the need for exogenous corticosteroid replacement for suspected adrenal insufficiency at any time during hospitalization. Results: BP measurements before and within 20 minutes after etomidate administration for RSI were recorded on 84 intubations (84%). The mean change in BP between pre-intubation and post-intubation measurements was a decrease of 1 mmHg (95% CI: -6 mmHg to +7 mmHg, P = 0.83). When expressed as a percentage of normal BP for age, the mean change in BP was a decrease of 1% (95% CI: -7% to +6%, P = 0.82). Four patients (4.8%; 95% CI: 1.3-11.7%) had a systolic BP decrease to below one SD of mean normal for age. Fourteen patients received corticosteroids during hospitalization, but none (0/99, 95% CI: 0-3.7%) for suspected adrenal insufficiency. Conclusions: We found no evidence of clinically important adrenocorticoid suppression and a low incidence of clinically important hypotension when using etomidate for emergent pediatric RSI. Because other induction agents may also result in hypotension, prospective comparison studies are needed to further evaluate the safety of etomidate in this patient population.

KW - Adrenal insufficiency

KW - Blood pressure

KW - Emergency department

KW - Etomidate

KW - Intubation

KW - Pediatric

UR - http://www.scopus.com/inward/record.url?scp=0033970194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033970194&partnerID=8YFLogxK

U2 - 10.1097/00006565-200002000-00005

DO - 10.1097/00006565-200002000-00005

M3 - Article

VL - 16

SP - 18

EP - 21

JO - Pediatric Emergency Care

JF - Pediatric Emergency Care

SN - 0749-5161

IS - 1

ER -